Related Subjects:
|Hodgkin Lymphoma
|Non Hodgkin Lymphoma
|Diffuse large B-cell lymphoma
|Intravascular large B-cell lymphoma
|Mantle cell lymphoma
|Marginal Zone Lymphoma
|Gastric (MALT) Lymphoma
|Primary CNS Lymphoma (PCNSL)
|Burkitt's lymphoma
|Follicular Lymphoma
๐ฉธ Hodgkin Lymphoma (HL) is a highly curable disease, with a 5-year survival of ~90% under current treatments. Classical HL has a much better prognosis than most types of non-Hodgkin lymphoma (NHL).
๐ About
- ~2,000 cases per year in the UK.
- More common in men than women.
- Malignant disorder of lymphoid cells, primarily affecting lymph nodes.
๐ Incidence
- ~4 new cases per 100,000 per annum.
- HL represents ~10% of all lymphomas; the rest are NHL.
- Bimodal age distribution: peak in young adults (15โ35) and another peak >50 years.
๐งฌ Aetiology
- More common in immunodeficiency & autoimmune disease.
- Epstein-Barr virus (EBV) often implicated, esp. in immunocompromised (HIV).
- B-lymphocyte predominates.
- Histological hallmark: Reed-Sternberg cells โ giant B-cells with mirror-image โowlโs eyeโ nuclei.
โ ๏ธ Risk Factors
- ๐ถ Age: Most common in 15โ35 and >55.
- โ๏ธ Gender: Slightly more common in men.
- ๐จโ๐ฉโ๐ง Family History: Lymphoma in relatives increases risk.
- ๐ฆ EBV infection: Linked to HL risk.
- ๐ก๏ธ Weakened immune system: HIV/AIDS, post-transplant immunosuppression.
๐ฌ Histological Subtypes
- Nodular Sclerosis: ๐ข Most common; young adults, esp. women; mediastinal nodes.
- Mixed Cellularity: Associated with HIV; commoner in older adults.
- Lymphocyte-Rich: Rarer; better prognosis; more in men.
- Lymphocyte-Depleted: Rare; aggressive; seen in older/HIV patients.
๐ Staging (Ann Arbor)
| Stage | Description |
| I | Single node group or single extralymphatic site |
| II | โฅ2 node groups, same side of diaphragm |
| III | Nodes ยฑ spleen on both sides of diaphragm |
| IV | Diffuse extranodal involvement (e.g. marrow, lung) |
| A | No systemic symptoms |
| B | Systemic โB symptomsโ (weight loss >10%, night sweats, fever) |
๐ฅ โB Symptomsโ
- Low-grade fever ๐ก๏ธ
- Drenching night sweats ๐ฐ
- Unexplained weight loss >10% โ๏ธ
- Reflect cytokine release โ worse prognosis.
๐งโโ๏ธ Clinical Features
- Fatigue, fevers, night sweats, weight loss.
- Pruritus (generalised itching).
- Breathlessness, bone pain, abdominal pain.
- Characteristic: Lymphadenopathy (firm, rubbery, non-tender, non-fixed).
- Common sites: Cervical, mediastinal, axillary nodes.
- Splenomegaly may be present.
- Unique: Lymph node pain after alcohol ๐ท (rare but exam favourite!).
๐งช Investigations
- Bloods: FBC, U&E, LFTs, ESR, Ca, Phosphate, ALP, LDH, urate.
- Definitive: Excisional biopsy of lymph node (>1 cm, persistent >4โ6 weeks).
- Bone marrow aspirate & trephine biopsy (for staging).
- Imaging: CT/MRI neck, thorax, abdomen, pelvis; PET-CT gold standard for staging and response.
- Baseline echocardiogram if anthracyclines planned (cardiotoxic).
๐ Management
- ๐ก HL is generally very curable, esp. when detected early. 5-year survival ~85โ90%.
- Limited/intermediate disease (IโIIA): Short chemotherapy (e.g. 2โ4 cycles ABVD) + involved-field radiotherapy.
- Advanced disease (IIIโIV): Chemotherapy systemic; RT only for bulky/residual disease.
- โ ๏ธ Always give irradiated blood products lifelong โ prevent transfusion-associated GVHD.
๐ Chemotherapy Regimens
- ABVD (standard of care): Adriamycin (doxorubicin), bleomycin, vinblastine, dacarbazine.
- Repeated q28 days = 1 cycle (usually 6 cycles).
- Toxicities: ๐จ Adriamycin โ cardiac, Bleomycin โ lung.
- eBEACOPP (more intensive, younger patients): escalated bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone.
- AVD + Brentuximab vedotin: Emerging option with intermediate toxicity profile. Requires G-CSF support.
- Older patients (>65โ75): Limit bleomycin (max 2 cycles) due to pulmonary toxicity.
- Relapsed/Refractory HL: High-dose chemo + autologous stem cell transplant (ASCT).
- Novel agents: Brentuximab vedotin, checkpoint inhibitors (nivolumab, pembrolizumab).
๐ References
๐งพ Clinical Case Examples โ Hodgkin Lymphoma
Case 1 โ Young Adult with Neck Lump ๐ฉโ๐
A 23-year-old woman presents with a painless swelling in her left neck for 3 months. She has drenching night sweats and 5 kg weight loss. On CXR, there is a widened mediastinum.
๐ Likely diagnosis: Classical Hodgkin lymphoma (nodular sclerosis subtype).
๐ Key points: Young adult, mediastinal mass, โB symptoms.โ
Case 2 โ Alcohol-Induced Node Pain ๐ท
A 30-year-old man reports pain in a long-standing cervical lymph node after drinking alcohol. He also has pruritus but no fever or weight loss.
๐ Likely diagnosis: Hodgkin lymphoma.
๐ Key points: Alcohol-induced pain is rare but highly exam-specific for HL.
Case 3 โ Older Adult with B Symptoms ๐ด
A 62-year-old man presents with fatigue, intermittent fevers, and weight loss. Exam reveals firm, rubbery, non-tender axillary and cervical lymphadenopathy. Biopsy shows ReedโSternberg cells (CD15+, CD30+).
๐ Likely diagnosis: Classical Hodgkin lymphoma.
๐ Key points: HL has a bimodal age distribution (15โ35, >55 years).
Case 4 โ Generalised Itch & Chest Mass ๐ซ
A 28-year-old woman presents with persistent pruritus and cough. CXR shows a bulky mediastinal mass.
๐ Likely diagnosis: Hodgkin lymphoma, mediastinal disease.
๐ Key points: Pruritus can be a paraneoplastic symptom of HL; mediastinal involvement is common.
Case 5 โ Relapsed Hodgkin Lymphoma ๐
A 35-year-old man treated for Hodgkin lymphoma at age 20 re-presents with enlarging supraclavicular lymph nodes. PET-CT confirms stage II relapse.
๐ Likely diagnosis: Relapsed Hodgkin lymphoma.
๐ Key points: Relapse occurs in ~10โ15% of patients; consider autologous stem cell transplant if fit.